Migraine. Migraine
Conditions
Interventions
Intervention group: Receiving Vitamin D.
Sponsors
Birjand University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Age 18 to 40 years Confirmation of migraine diagnosis by a neurologist Availability of the desired information Having informed consent to participate in the study
Exclusion criteria
Exclusion criteria: Patients who do not have the necessary cooperation Suffering from cardiovascular diseases, liver diseases, kidney diseases, primary hyperparathyroidism, tension headache, and hypervitaminosis D Use of corticosteroids and contraceptives Using vitamin D, magnesium, calcium, folic acid, vitamin B6, and vitamin B12 supplements before entering the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Migraine headache indices including migraine severity, average duration of migraine attacks per day, and frequency of migraine attacks per month. Timepoint: Migraine headache indices including migraine severity, average duration of migraine attacks per day, and frequency of migraine attacks per month. Method of measurement: Migraine severity will be determined by VAS scale. The result of daily headache will be calculated by multiplying the duration of headache attacks by the headache frequency. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ali Fanoodi
Birjand University of Medical Sciences
Outcome results
None listed